Company Data
Aptose Biosciences Inc.
Ticker
APS:CA
Current Price
$2.12 -3.2%
Market Cap
$5.4M
Price Target
Refer to Report
Volume
4.0K
52wk Range
$1.02 - $5.8
Overview
Aptose Biosciences Inc is a biotechnology company. It develops targeted medicines and personalized therapies for the precision treatment of life-threatening cancers such as acute myeloid leukemia, myelodysplastic syndromes and other hematologic malignancies and also therapies for Oncology. The firm has CG-806, APTO-253 drugs in preclinical development stage pipeline.